ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
17.40
-0.50 (-2.79%)
Dec 20, 2024, 4:00 PM EST - Market closed
ADMA Biologics Market Cap
ADMA Biologics has a market cap or net worth of $4.11 billion as of December 20, 2024. Its market cap has increased by 382.83% in one year.
Market Cap
4.11B
Enterprise Value
4.14B
1-Year Change
382.83%
Ranking
Category
Stock Price
$17.40
Market Cap Chart
Since October 17, 2013, ADMA Biologics's market cap has increased from $50.20M to $4.11B, an increase of 8,093.61%. That is a compound annual growth rate of 48.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 4.11B | 302.70% |
| Dec 29, 2023 | 1.02B | 33.78% |
| Dec 30, 2022 | 763.50M | 176.53% |
| Dec 31, 2021 | 276.10M | 49.73% |
| Dec 31, 2020 | 184.40M | -22.29% |
| Dec 31, 2019 | 237.30M | 114.17% |
| Dec 31, 2018 | 110.80M | -12.41% |
| Dec 29, 2017 | 126.50M | 91.67% |
| Dec 30, 2016 | 66.00M | -23.70% |
| Dec 31, 2015 | 86.50M | -16.67% |
| Dec 31, 2014 | 103.80M | 44.37% |
| Dec 31, 2013 | 71.90M | 43.23% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 4.58B |
| Integer Holdings | 4.47B |
| TG Therapeutics | 4.42B |
| PROCEPT BioRobotics | 4.40B |
| Axsome Therapeutics | 4.30B |
| Apellis Pharmaceuticals | 4.18B |
| Arcellx | 4.03B |
| Ultragenyx Pharmaceutical | 3.98B |